TScan Therapeutics, Inc. (TCRX) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US89854M1018
TScan Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 10.33 m USD |
| Operating income | -135.81 m USD |
| EBIT | -127.00 m USD |
| Net income | -129.77 m USD |
| Diluted EPS – continuing operations | -1.00 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About TScan Therapeutics, Inc.
TScan Therapeutics, Inc., a clinical-stage biotechnology company, develops T cell receptor-engineered T cell (TCR-T) therapies for the treatment of patients with cancer in the United States. The company's lead product is TSC-101, for the treatment of patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), and acute lymphoblastic leukemia (ALL) in patients undergoing allogeneic hematopoietic cell transplantation (HCT), which is in Phase I clinical trial, as well as eliminates residual disease and promotes donor chimerism. It also develops TSC-102-A01 and TSC-102-A03, which are allogeneic and donor-derived TCR-T therapy candidates targeting epitopes. In addition, the company develops TSC-200, TSC-201, TSC-202, TSC-203, and TSC-204 for the treatment of solid tumors. It has a research collaboration and license agreement with Amgen Inc. to identify antigens recognized by T cells in patients with Crohn's disease. TScan Therapeutics, Inc. was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
More stocks
- Bimergen Energy Corp (BESS)
- Binah Capital Group, Inc. (BCG)
- CYBERLOQ TECHNOLOGIES, INC. (CLOQ)
- AMC Robotics Corp (AMCI)
- CIRCLE8 GROUP INC (CIRC)
- PETMED EXPRESS INC (PETS)
- NOCOPI TECHNOLOGIES INC/MD/ (NNUP)
- Aligos Therapeutics, Inc. (ALGS)
- WM TECHNOLOGY, INC. (MAPS)
- VenHub Global, Inc. (VHUB)
- Lung Ming Green Energy Technology Engineering Co Ltd (3018.TW)
- DocGo Inc. (DCGO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.